Nagaileben Co., Ltd.

Equities

7447

JP3647000003

Medical Equipment, Supplies & Distribution

Delayed Japan Exchange Other stock markets 08:44:23 2024-04-24 pm EDT			5-day change	1st Jan Change
2,338 ^JPY	+0.56%		+1.12%	-1.85%

Apr. 02	Nagaileben Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.57% for ¥1,000 million.	CI
Apr. 02	Nagaileben Co., Ltd. authorizes a Buyback Plan.	CI

Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 31, 2021

April 05, 2021 at 02:00 am EDT

Nagaileben Co., Ltd. provided dividend guidance for the year ending August 31, 2021. For the year, the company expects dividend of JPY 60.00 per share against JPY 60.00 per share paid for the same period a year ago.

Latest news about Nagaileben Co., Ltd.

Nagaileben Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.57% for ¥1,000 million.	Apr. 02	CI
Nagaileben Co., Ltd. authorizes a Buyback Plan.	Apr. 01	CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 2024	Dec. 27	CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and the Fiscal Year Ending August 2024	Dec. 27	CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023.	Dec. 12	CI
Nagaileben Co., Ltd.'s Equity Buyback announced on June 29, 2023, has expired with 454,300 shares, representing 1.41% for ¥999.81 million.	Dec. 10	CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023.	Dec. 04	CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending Feb. 2024 and the Fiscal Year Ending August 2024	23-10-02	CI
Nagaileben Co., Ltd. Announces Dividend for the Year Ended August 2023; Payable on November 27, 2023; Provides Dividend Guidance for the Year Ending August 2024	23-10-02	CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023.	23-09-04	CI
Nagaileben Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.55% for Â¥1,000 million.	23-06-29	CI
Nagaileben Co., Ltd. authorizes a Buyback Plan.	23-06-28	CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023	23-04-04	CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2023 and Full Year Ending August 2023	22-12-27	CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending August 31, 2023	22-12-27	CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023	22-10-03	CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 31, 2023	22-10-03	CI
Nagaileben Co., Ltd. Provides consolidated Earnings guidance for the fiscal year Ending August 31, 2022	22-06-29	CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 31, 2022	22-06-29	CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022.	22-05-16	CI
Nagaileben Co., Ltd.'s Equity Buyback announced on May 16, 2022, has expired with 132,700 shares, representing 0.4% for ¥254.65 million.	22-05-16	CI
Nagaileben Co., Ltd. announces an Equity Buyback for 200,000 shares, representing 0.62% for ¥400 million.	22-05-16	CI
Nagaileben Co., Ltd. authorizes a Buyback Plan.	22-05-15	CI
Nagaileben's Fiscal H1 Profit Tumbles as Sales Fall	22-04-05	MT
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on April 4, 2022.	22-04-04	CI

Chart Nagaileben Co., Ltd.

Duration

Period

More charts

Company Profile

NAGAILEBEN Co., Ltd. is a Japan-based company mainly engaged in the medical wear business. The Company operates medical wear business. The medical wear business purchases and sells medical wear products used by medical professionals and care workers from subsidiaries. In addition, the Company is also engaged in the sale of shoes and other products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-06-26 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Nagaileben Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

SELL

Number of Analysts

Last Close Price

2,325 JPY

Average target price

2,000 JPY

Spread / Average Target

-13.98%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Supplies

	1st Jan change	Capi.
NAGAILEBEN CO., LTD.	-1.85%	490M
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-34.69%	2.92B
WINNER MEDICAL CO., LTD.	-9.29%	2.72B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+2.61%	2.04B
HARTALEGA HOLDINGS	-0.74%	1.91B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-13.01%	1.87B
TOP GLOVE CORPORATION BHD.	-5.56%	1.42B
NAKANISHI INC.	-2.70%	1.24B
KOSSAN RUBBER INDUSTRIES	+14.05%	1.13B
KANGJI MEDICAL HOLDINGS LIMITED	+4.43%	1.13B

Medical Supplies